Haematology - Anaemia: IDA, Thalassemia, Megaloblastic anemia, Polycythemia Flashcards

1
Q

S/S of anemia

A

Symptoms of anaemia: due to ↓O2 delivery
□ Acute/severe: SOB (esp on exertion), palpitation, dizziness/syncope (may be postural)
□ Chronic/insidious: fatigue, Low exercise tolerance, SOB on exertion, pallor

□ Symptoms from causes, eg. menorrhagia, tarry stool, bone pain, hypovolaemia

□ Complications: cardiac ischaemia, thrombocytopenic bleeding, ↑mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

S/S of following causes of anemia

  • Uremia
  • Haemolysis
  • Megaloblastic anemia
  • Haematological malignancy
  • Hypersplenism
  • Marrow infiltration
A

□ Uremia: café au lait complexion, uremic fetor, flapping tremor

□ Haemolysis: jaundice, ± mild/moderate splenomegaly

□ Megaloblastic anaemia: premature greying of hair, skin hyperpigmentation, atrophic glossitis, jaundice, oral ulcers, SCD, PN, Psychiatric complications

□ Haematological malignancy: lymphadenopathy, hepatosplenomegaly

□ Hypersplenism: isolated splenomegaly

□ Marrow infiltration: signs of infection elsewhere (leukopenia), mucocutaneous bleeding (thrombocytopenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List all Red cell indices

A

Haemoglobin (HGB)

Mean corpuscular volume (MCV)

Mean corpuscular haemoglobin (MCH)

MCH concentration (MCHC)

Red cell distribution width (RDW)

RBC count (RBC)

Haematocrit (HCT)

Reticulocyte count (RET)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Haemoglobin level

  • Normal ref. interval
  • Definition
A

14.0-17.5 g/dL (M) 12.3-15.3 g/dL (F)
Concentration of haemoglobin per unit volume blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MCV

Normal reference interval

Definition

Clinical relevance

A

80-96 fL

Average volume per RBC

Most important
Classifies anaemia into micro-, normo-, macrocytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mean corpuscular haemoglobin

Reference interval

Definition

Clinical relevance

A

28-33 pg/RBC

Average Hb content per RBC

Used to double check MCV as prolonged storage can lead to RBC swelling due to temperature changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MCHC

Normal reference range

Definition

Clinical relevance

A

33-36 g/dL RBC

Average Hb concentration per RBC

Very high = spherocytosis
Low = Fe def anaemia, thalassaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Red cell distribution width

Reference interval

Definition

Clinical relevance

A

12-15% CV

Degree of anisocytosis, i.e. variation in RBC size

Increased in reticulocytosis, Fe def anaemia and severe thalassemia (not in trait)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RBC count

Normal reference interval

Definition

Clinical relevance

A

4.5-5.9×109/L (M)
4.1-5.1×109/L (F)

Number of RBCs per unit volume whole blood

Parallels HGB and HCT except in extreme microcytosis, eg. thalassemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Haematocrit

Normal reference

Definition

Clinical relevance

A

42-50% (M)
36-45% (F)

Volume of intact RBC per unit volume blood (as percentage)

Usually parallels HGB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Reticulocyte count

Normal reference range

Definition

Clinical relevance

A

0.02-0.11×109/L
0.5-2% total RBC

Percentage of reticulocytes among RBCs

Increase signifies intact marrow compensation + adequate EPO and therefore likely ↑consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of Falsely elevated WBC count + anemia

A

falsely high due to circulating nucleated RBCs

Anemia: Severe hemolysis, acute hemorrhage
Acute hypoxia
Hyposplenism
Cancer: myelofibrosis, extramedullary erythropoiesis, marrow infiltration by leukemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ddx Thrombocytopenia + anemia

Ddx thrombocytosis + anaemia

A

Thrombocytopenia + anemia: DIC and thrombotic microangiopathies (TMAs), marrow infiltration by hematological malignancies

thrombocytosis + anaemia: chronic Fe deficiency, MPN, inflammatory/neoplastic disease e.g. CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe following picture and give Ddx

A

Microcytosis (MCV<76)

Iron deficiency

Sideroblastic aneaemia

Thalassaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe following picture and give Ddx

A

Macrocytosis (MCV > 100fl)

Vitamin B12/ Folate deficiency

Liver disease, Alcohol

Hypothyroidism

Drugs: Zidovudine, Trimethoprim, Phenytoin, Methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe following picture and give Ddx

A

Target cell (central area of Hemoglobinization)

Liver disease

Thalassemia

Post-splenectomy

Haemoglobin C disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe following picture and give Ddx

A

Spherocytes (no central pallor)

Autoimmune haemolytic anaemia

Post-splenectomy

Hereditary spherocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe following picture and give Ddx

A

Red cell fragments (Intravascular hemolysis)

Macroangiopathic hemolysis e.g. TTP

DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe following picture and give Ddx

A

Nucleated red blood cells (normoblast)

Marrow infiltration

Myelofibrosis

Severe haemolysis

Acute haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe following picture and give Ddx

A

Howell-Jolly bodies (small nuclear remnants)

Hyposplenism

Post-splenectomy

Dyshaematopoiesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe following picture and give Ddx

A

Polychromasia (reticulocyte present)

Haemolysis

Acute haemorrhage

Increased red cell turnover

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Causes of the following poikilocytes

Rouleaux formation

Macro-ovalocytes

Tear-drop RBC

Bite cells

RBC parasite inclusion

Basophilic stippling

A

Rouleaux formation - Paraproteinaemia

Macro-ovalocytes - Megaloblastic anaemia

Tear-drop RBC - Myelofibrosis

Bite cells - G6PD/ oxidative haemolysis

RBC parasite inclusion - Malaria, Babesiosis

Basophilic stippling - Lead poisoning, Dyshaematopoiesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

2 major mechanisms and sub-categories that cause anaemia *****

How to differentiate?

A
  1. Decreased RBC production - Low reticulocyte count
  • Inadequate RBC production by Erythroid hypoplasia in bone marrow
  • Ineffective erythropoiesis by Erythroid hyperplasia in bone marrow
  1. Increased peripheral consumption - High reticulocyte count
  • Increase destruction of circulating RBC (Hyperplastic marrow)
  • Increase blood loss (Hyperplastic marrow)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Causes of inadequate RBC production (erythroid hypoplasia)

A

Failure of trophic mechanism:
□ Chronic renal failure (↓EPO)
□ Hypothyroidism

Inadequate iron: rate-limiting step
□ Iron deficiency anaemia
□ Anaemia of chronic disease (ACD)

Bone marrow suppression:
□ Drugs, esp chemotherapy, cotrimoxazole
□ Irradiation

Bone marrow disorders:
□ Malignant infiltration
□ Aplastic anaemia
□ Pure red cell aplasia (PRCA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Causes of ineffective erythropoiesis (erythroid hyperplasia)

A

 Megaloblastic anaemia
 α and β-thalassaemia (*usu ↑reticulocyte count)
 Myelodysplastic syndromes
 Sideroblastic anaemia and lead poisoning
 Congenital dyserythropoietic anaemia (CDA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Causes of peripheral RBC destruction

A

Intrinsic RBC defects:
□ Enzyme deficiencies, eg. G6PD def
□ Hb defects, eg. thalassemia, Hb-pathy
□ Membrane defects, eg. hereditary spherocytosis, elliptocytosis

Extrinsic RBC defects:
□ Mechanical, eg. mechanical heart valve
□ Infections, eg. malaria
□ Immune: warm- or cold-reacting, drug-induced, alloimmune
□ Microangiopathic haemolytic anaemia (MAHA), eg. DIC, TTP

Hypersplenism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Causes of blood loss leading to anaemia

A

 GI bleeding (most common in general)

 Menorrhagia (most common in young F)

 Haematuria (uncommon)

 Trauma and surgery

 Respiratory tract bleeding

 Occult bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Causes of Microcytic anaemia

A

 Iron deficiency anaemia
 Thalassaemia intermedia and major
 Anaemia of chronic disease/inflammation (some)
 Sideroblastic anaemia (congenital and acquired) and lead poisoning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Causes of Normocytic anaemia

A

 Acute bleeding (haemodilution) and early/recovering iron deficiency anaemia
 Anaemia of chronic disease/inflammation (ACD)
 Marrow suppression, eg. cancer, aplastic anaemia, infection
 Chronic renal insufficiency
 Microcytic anaemia masked by reticulocytosis
 Haemolytic anaemia (can be normal or high)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Causes of Macrocytic anaemia

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Causes of Macrocytic RBC with no anaemia

A

*Causes of macrocytosis without anaemia include

Reticulopenic, macrocytic RBC:
 Hypothyroidism and liver disease due to lipid abnormalities
 Chronic alcoholism
 Drugs interfering with nucleic acid metabolism, eg. zidovudine, methotrexate, trimethoprim, phenytoin, TKIs)

Cell swelling and water retension:
 CO2 retention (e.g. COPD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Outline investigation pathway for normocytic or microcytic anaemia

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Outline investigative pathway for Macrocytic anaemia

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Polycythaemia

Definition

Cut-offs

A

Polycythaemia: defined as abnormal elevation of haemoglobin and/or haematocrit in peripheral blood
□ Increased haemoglobin as defined as >16.5g/dL (M) and >16.0g/dL (F)
□ Increased haematocrit as defined as >49% (M) and >48% (F)

35
Q

Compare relative vs absolute polycythaemia

A

□ Relative polycythaemia: spurious ↑Hb/Hct due to loss of plasma volume (i.e. haemoconcentration)
→ Causes: diuretics, vomiting/diarrhoea, obesity, heavy smoking, Gaisbock syndrome

□ Absolute polycythaemia: true ↑Hb/Hct due to ↑total body RBC mass, which can be divided into
→ Primary polycythaemia due to autonomous production of RBCs
→ Secondary polycythaemia due to ↑serum erythropoietin

36
Q

Causes of Primary absolute polycythaemia

A

Primary (EPO = ↓/0)

Congenital: erythropoietin receptor mutations, congenital methaemoglobinaemia

Polycythemia rubra vera (due to JAK2 mutation)

Other myeloproliferative neoplasms (due to JAK2, MPL, CALR mutations)

37
Q

Causes of secondary absolute polycythaemia

A

Secondary (↑EPO)

Hypoxia-associated ↑EPO:

chronic pulmonary disease, cyanotic heart diseases, obstructive sleep apnoea, high altitude, chronic CO poisoning (incl heavy smoking)

Inappropriately increased erythropoietin:
Renal diseases: renal artery stenosis, hydronephrosis, cysts, post-transplant

EPO-producing tumours: HCC, RCC, haemangioblastoma, phaeochromocytoma, uterine leiomyoma

Performance-enhancing drugs in athletes, eg. recombinant erythropoiesis-stimulatint agents, autologous transplantation, androgens/anabolic steroids

38
Q

Symptoms of primary myeloproliferative neoplasms (giving primary absolute polycythaemia)

A

Symptoms of primary myeloproliferative neoplasms:
→ Hyperviscosity: chest/abd pain, myalgia/weakness, fatigue, headache, ↓VA, slow mentation

→ Thrombosis/bleeding: thrombosis at unusual sites, excessive bleeding/bruising

→ PV-related: unexplained fever, sweats, weight loss, aquagenic pruritus, erythromelalgia, gout

39
Q

Panel of investigations for Polycythaemia

A

CBC, PBS: ↑other lineages, immature WBC, leucoerythroblastic picture → suggests MPN
Urinalysis, L/RFT: for possible renal diseases and HCC
Pulse oximetry for tissue hypoxia
Serum EPO: low or absent serum EPO → relatively specific for MPN and PV
JAK2 testing for V617F mutation in PV

□ Further screen for 2o causes if JAK2 mutation negative + no clear 2o causes
Total red cell mass (by radiolabeling RBCs) to confirm absolute erythrocytosis
Sleep study for OSA
→ USG abdomen for abdominal tumours (ectopic EPO)
→ Lung function tests for respiratory diseases

□ Bone marrow aspirate + trephine if suspicious of myeloproliferative neoplasms

40
Q

Causes of hereditary microcytosis/ microcytic anaemia

A

Defects in globin synthesis:
Thalassaemia
Thalassaemic Hbpathies, eg. HbE

Defects of iron metabolism:
Iron-refractory iron deficiency anaemia
DMT1 mutation
Atransferrinaemia

Defects in porphyrin synthesis:
Inherited sideroblastic anaemia

41
Q

Causes of hereditary microcytosis/ microcytic anaemia

A

Defects in globin synthesis
Thalassaemia
Thalassaemic Hbpathies, eg. HbE

Defects of iron metabolism
Iron-refractory iron deficiency anaemia
DMT1 mutation
Atransferrinaemia

Defects in porphyrin synthesis
Inherited sideroblastic anaemia

42
Q

Causes of acquired microcytosis/ microcytic anaemia

A

Iron deficiency anaemia (IDA)

Anaemia of chronic disease (majority normocytic)

Acquired sideroblastic anaemia due to lead poisoning, alcohol, drugs

Copper deficiency (some)

Zinc toxicity

43
Q

Panel of investigations for microcytosis

A

↑RDW: non-specific

RBC count: ↓ in Iron deficiency anaemia (IDA), N/↑ in thalassaemia

Iron profile and Hb studies for IDA and thalassaemia respectively

Blood smear:
→ Thalassaemia: marked anisopoikilocytosis (↑variation in RBC size/morphology) incl target cells, teardrop cells
→ Fe def: anisopoikilocytosis (↑variation in size and shape), but many have normal-looking RBCs
→ Anaemia of chronic disease: majority have normal sized, shape RBCs, but a subset may have microcytosis (accounts for ↓MCV)
→ Sideroblastic anaemia: ringed sideroblasts with a ring of iron granules surrounding nucleus
→ Lead poisoning: characterized by basophilic stippling (denatured RNA)

BM examination: rarely necessary if isolated McHc anaemia

44
Q

Iron deficiency anaemia

Outline the CBC: HBG, MCV, RDW, RBC

Iron profile: (Serum Fe, IBC, %Tf saturation, Serum ferritin)

Reticulocyte count

CRP

A
45
Q

Thalassaemia

Outline the CBC: HBG, MCV, RDW, RBC

Iron profile: (Serum Fe, IBC, %Tf saturation, Serum ferritin)

Reticulocyte count

CRP

A
46
Q

Anaemia of chronic disease

Outline the CBC: HBG, MCV, RDW, RBC

Iron profile: (Serum Fe, IBC, %Tf saturation, Serum ferritin)

Reticulocyte count

CRP

A
47
Q

Hepcidin

  • Function
  • Causes of high hepcidin state
  • Causes of low hepcidin state
A

Function: Internalize ferroportin in gut lumen >> decrease absorption of iron from gut into blood >> decrease serum iron

High hepcidin state:

  • Inflammation/ Infection >> inflammatory cytokines >> Induce hepcidin secretion from liver

Low hepcidin state:

  • Anaemia
  • Hypoxia
  • Low iron stores
48
Q

Factors that decrease iron absorption in GIT

A

High hepcidin state: Infection/ Inflammatory state

Low stomach acid (acid for reduction of iron): Gastrectomy, Long-term PPI use, Autoimmune gastritis

Low reducing agent: e.g. low Vitamin C

Iron overload

Duodenum/ small intestine pathologies/ resection causing malabsorption

49
Q

Describe the recycling and storage of iron in body

A

Internal cycling of iron:
□ Transferrin (Tf): iron transported in plasma bound to transferrin → each Tf binds 2× Fe3+
□ Utilization: used to form erythroid precursors in BM
□ RBC cycling: RBCs broken down by reticuloendothelial system (liver, spleen) and iron returned into plasma as transferrin-bound form

Storage of iron:
□ Form: ferritin and haemosiderin
□ Site: reticulo-endothelial system (RES), i.e. macrophages of liver, bone marrow and spleen → derived almost entirely from phagocytosis of senescent erythrocytes or defective developing red cells

50
Q

Causes of iron deficiency

A

Frank bleeding
*GI bleeding
*Trauma- and surgery-related bleeding
*Severe Haemoptysis
*Menorrhagia

Occult bleeding/iron loss:
Iatrogenic: frequent blood donation, excessive blood taking, haemodialysis
Occult/underestimated bleeding

Functional Iron deficiency - Post- EPO treatment

Urinary and pulmonary haemosiderosis

Malabsorption: H. pylori-related atrophic gastritis, coeliac disease, gastrectomy/gastric bypass, autoimmune gastritis

Inadequate intake (extremely rare, iron store lasts years)

51
Q

Compare absolute and functional iron deficiency

A

Absolute deficiency: absence/severely ↓iron stores in RES

Functional deficiency (iron-restricted erythropoiesis): adequate Fe for normal erythropoiesis but iron is not available for RBC, due to

  • ACD: ↑hepcidin → ↓ferroportin expression → ↓iron release into circulation
  • EPO: release into circulation not rapidly enough to respond to EPO
52
Q

Iron deficiency anaemia

Outline typical CBC, PBS, BM exam results

A

CBC:

  • *McHc anaemia** with ↓RBC count, ↓reticulocyte count
  • *Reactive thrombocytosis** due to ↑stimulation of platelet precursors by ↑EPO

PBS:

hypochromic microcytic red cells with anisopoikilosis
May be dimorphic in concurrent megaloblastic anaemia or iron supplement treatment

BM: not routinely done
Active erythropoiesis but poorly haemoglobinized (micronormoblastic)
Iron stain shows ↓/absent marrow iron stores

53
Q

Iron deficiency anaemia

Describe typical iron profile and limitations of each metric

A

Iron studies:

↓serum iron: influenced by inflammatory state, dietary intake, diurnal variation → NOT diagnostic
↑serum transferrin/TIBC but ↓Tf saturation: <16% compatible with IDA (less specific than ferritin)
↓serum ferritin: diagnostic of IDA (most Spec)
- FN: acute phase reactant → FN if inflammatory state
- FP: very rarely, hypothyroidism, vit C deficiency
↑soluble Tf receptor (sTfR): reflects ↑erythropoiesis

54
Q

Investigations to find cause of Iron Deficiency anaemia

A

□ Hx: bleeding Hx (GI, urine, menses, bleeding disorders), blood donation, RFs for GI cancers, drug Hx (NSAID, anticoagulants), previous scopes

□ P/E: as appropriate, include PR exam

□ Ix: look for occult GI bleeding first
FOBT×3 if >50y
Stool examination × ova/cyst in tropical areas
Upper endoscopy then colonoscopy if either IDA or FOBT+
→ Consider non-GI and small bowel causes if endoscopy –ve

55
Q

Management of Iron deficiency anaemia

Indication for different options, dosing, side effects

A

□ Treat underlying cause

Oral iron for majority of patients
Dosing: 150-200mg elemental iron per day until Fe profile normalized (~3-6mo)
Choice: Iron sulphate tablet, ferrum hausmann chewable tablet
Effect: ↑Hb by ~1g/dL every 7-10d with reticulocyte response in 1w
S/E: GI S/E very common → metallic taste, dyspepsia, Nausea and vomiting, altered bowel habits, black stools

IV iron if refractory to oral iron, with severe ongoing blood loss or malabsorption

Choice: ferric carboxymaltose, ferric gluconate, ferumoxytol, iron sucrose, iron isomaltoside
Advantage: effective, rapid correction, ensure good compliance, no GI S/E

Transfusion if angina, heart failure, cerebral hypoxia or Hb <7g/dL

56
Q

Anaemia of chronic disease

Pathogenesis

A

Pathogenesis: result from body’s normal response to limit availability of iron for invading microbes

□ Dysregulated iron homoeostasis:

Inflammation/ LPS in bacterial infection >> ↑ IL-6 and other cytokines >> Increase transcription and translation of Hepcidin in liver >> Hepcidin internalize ferroprotein in gut mucosa and macrophages in RES >> Decrease GI absorption of Fe and MQ release of Fe

Immune effect on erythropoiesis:
→ ↓EPO secretion by kidneys
→ ↓erythropoiesis
→ ↓RBC survival by ↑free radical formation → ↑RBC damage → ↑RBC turnover

57
Q

Diseases asso. with Anaemia of chronic illness

A

□ Systemic inflammatory/ Autoimmune disease, eg. RA, SLE

□ Infections: related to disease severity

□ Cancer, esp haematological malignancies

□ Chronic organ impairment: heart failure, COPD

□ Chronic solid-organ rejection after transplant

□ Chronic Kidney disease/ inflammation

58
Q

Anaemia of chronic disease

CBC, PNS, BM exam and Iron profile typical results

A

□ CBC: Mild NcNc anaemia, can be McHc (<1/4) with low reticulocyte count

□ PBS: relatively uniform population of normocytic RBCs w/o evidence of haemolysis

□ BM: iron stain shows N/↑ iron in MQ, ↓/no iron in erythroid precursors (both –ve in IDA)

□ Iron studies: ↓serum iron, ↓total Tf/TIBC, ↓Tf saturation, N/↑ ferritin

□ ↑CRP/ESR

59
Q

How to differentiate anaemia of chronic illness from concomitant iron deficiency

A

Differentiating from or identifying concomitant Fe deficiency:

→ Suggestive features: MCV (↓ in IDA, Normal in ACD), Ferritin (↓ in IDA, ↑ in ACD)

→ Differentiating features: sTfR (↑ in IDA, ↓ in ACD), hepcidin (↓ in IDA, ↑ in ACD)

→ Therapeutic trial of iron may be given in difficult situations

60
Q

Alpha thalassaemia

Gene affected and type of gene defect

Pathogenesis and effects

A

Genetics: HBA1/2 code for same α-globin chain in α-gene cluster (ch16)

One person has four genes → α0 (0 α genes) to α4 (4 α genes) presents with a spectrum of varying disease severity

Majority are deletions (90%)

Pathogenesis: mutated HBA1/2 resulting in ↓α-globin synthesis
α-globin required for production of both fetal (α2γ2) and adult (α2β2) Hb → affects both fetus and adults

Effects:

→ Fetus: excess γ chains form Hb Bart’s (γ4)
→ Adults: excess β chains form Hb H (β4)
→ Result: abnormal HbH tetramer unstable → ↑haemolysis

61
Q

Compare the 4 phenotypes of Alpha thalassaemia

Underlying genetic defect

Effect on RBC

A

A-thal. minima (silent carrier) - 1 gene deletion, i.e. αα/α-; no effect on MCV and Hb analysis

A-thal minor (Thal. trait) - 2 gene deletions, i.e. αα/– (SE Asians), α-/α- (Blacks); may have hypochromia/microcytosis with mild anaemia

A-thal intermedia (HbH disease) - 3 gene deletions, i.e. α-/– → excessive HbH (β4); Transfusion-dependent, moderate McHc anaemia

A-thal major (Hb Bart’s hydrops fetalis) - 4 gene deletions, i.e. –/– → Hb Bart’s (γ4) in fetal blood; Severe fetal anaemia culminating in hydrops fetalis (fetal high-output HF)

62
Q

Beta-thalassaemia

Gene affected and type of genetic defect

Pathogenesis

A

Genetics: single HBB gene code for β-globin chain in β-gene cluster (ch11)
Majority due to point mutations instead of deletions

Majority compound heterozygotes → clinical severity depends on combination and nature of mutation in each of the two HBB gene

Pathogenesis:
→ α-globin only required for production of adult HbA, HbA2 → only becomes manifest at ≥6y/o
→ α4 tetramer is unstable, precipitate into inclusion bodies → damage RBC membrane and ineffective erythropoiesis
→ Free α-chains in peripheral RBCs → aggregate and precipitate → ↑haemolysis

Other sources of variability in clinical severity:

  • Genetic determinant of HbF level: HbF can compensate partly for function of HbA
  • Configuration of α cluster: excessive α alleles → ↑imbalance → ↑clinical severity
63
Q

Compare the 3 syndromes of Beta thalassaemia

Underlying genetic defect

Effect on RBC

A

β-thal minor (thal trait)
*β/β+ or β/β0; asymptomatic mild anaemia with marked microcytosis

β-thal intermedia
*β+/β+, β+/β0 (majority)
*transfusion-independent anaemia
(β-thal minor with exacerbating genetic variant (eg. triplicated/quadriplicated α genes, HbE) or β-thal major with alleviating genetic variant are also classed as intermedia)

β-thal major (Cooley’s anaemia)
*β0/β0, β0/β+ or β+/β+ with very low β-chain production (rare)
*lifelong transfusion-dependent anaemia with onset at 6-12mo
*Hemolytic symptoms, progress to high-output HF, FTT, Infection, iron overload…etc

64
Q

Thalassaemia

Manifestations of extramedullary haematopoiesis

A

Splenomegaly due to extramedullary haematopoiesis and haemolysis

  • Common in thal major, some thal intermedia
  • Hypersplenism may exacerbate situation

Hepatomegaly due to extramedullary haematopoiesis and iron overload

  • Early-life symptom, cirrhosis with long iron overload

Nephromegaly

Jaundice, dark urine, pigment gallstones

65
Q

Manifestations of iron overload

A

Childhood onset in those with chronic transfusion w/o chelation, adult onset in those with intermedia or transfusion w/ chelation

Chronic liver disease: hepatomegaly, cirrhosis, HCC

Endocrine and metabolic abnormalities due to iron deposits in endocrine glands
Hypogonadism: delayed puberty, oligo/amenorrhoea, ↓libido, ↓2o sexual features
Hypothyroidism
Insulin resistance during 2nd decade of life and DM (bronze diabetes)

Leaden-grey skin pigmentation

Infection by sideroophilic organisms, eg. L. monocytogenes, Yersinia enterolitica, Salmonella enterica, Klebsiella pneumoniae and E. coli

66
Q

Thalassaemia

Skeletal abnormalities in severe cases?

A

Due to marrow expansion from ineffective erythropoiesis

  • ‘Chipmunk’ facies
  • Change in body habitus: Convex ribs and limb bones, Shortened limbs
  • Osteopenia/ Osteoporosis
  • Growth impairment/ delay
  • Bony masses (expanding marrow break bone cortex
67
Q

Cardiovascular and pulmonary manifestations of thalassaemia

A

Cardiovascular:

  • Major cause of death in thalassaemia
  • Heart failure
  • Bradyarrhythmia
  • Thromboembolism due to hypercoagulation

Pulmonary:

  • Pulmonary hypertension
  • Asymptomatic pulmonary dysfunction: e.g. restrictive ariway/ obstructive defects, decrease VO2 max…etc
68
Q

Investigations for thalassaemia

A

CBC:

  • McHc anaemia with marked ↓MCV, N/↑ reticulocyte13 and ↑RBC
  • Mentzer index (MCV/RBC count): >13 = IDA, <13 = thalassaemia trait

PBS:

  • profoundly hypochromic microcytic red cells with bizarre RBC morphology (target, pencil cells)

Markers of haemolysis: ↑LDH, ↑unconj bilirubin, ↓haptoglobin, ↑methaemalbumin, DAT –ve

Iron studies: ↑serum iron, ↑Tf sat, ↑ferritin due to iron overload

Haemoglobin studies:

Hb electrophoresis for beta

Supravital stain for alpha (HbH)

DNA-based genotyping

69
Q

Management of thalassemia (severe e.g. thal major/ intermedia with hemolysis)

A

Folate supplementation

Low iron diet, eg. avoid red meat, spinach

Regular transfusion: mainstay of treatment

  • hypertransfusion to maintain stable Hb level and suppress ineffective erythropoiesis
  • use leukodepleted packed cells to ↓FNHTR and TRALI

Iron chelation: for B-thal major

Splenectomy

Allogeneic HSCT

70
Q

Causes of macrocytosis and macrocytic anaemia

A
  • *Abnormal DNA metabolism**
  • *- Vitamin B12 deficiency**
  • *- Folate deficiency**
  • Copper deficiency
  • Drugs, including antiretroviral, cytotoxic agent, immunosuppressant, TKI

Primary marrow disorder

  • Myelodysplastic syndrome (esp in elderly)
  • Congenital dyserythropoietic anaemia
  • Sideroblastic anaemia (some)
  • LGL leukaemia

Reticulocytosis:

  • Haemolytic anaemia
  • Stress-induced erythrocytosis

Lipid abnormalities

  • Liver disease
  • Hypothyroidism

Others:

  • *Alcohol abuse**
  • *Multiple myeloma** and other plasma cell dyscrasia
71
Q

Investigations for macrocytosis

A

CBC:

  • *Severe macrocytosis (MCV >110-115) → almost exclusively megaloblastic anaemia**
  • *≥1 additional cytopenias → Primary BM problem, eg. megaloblastic anaemia, MDS**

PBS:
→ Megaloblastic anaemia: macro-ovalocytes, hypersegmented neutrophils (>5 lobes)
→ Liver disease: target cells
→ Myelodysplastic syndrome: hypolobulated or hypogranular, dysplastic neutrophils

□ Ix for cause:
→ Reticulocyte count: ↑ in haemolysis, ↓ in BM disorders
→ Serum B12 and folate (± copper if gastric bypass) for megaloblastic anaemia
→ TFT for hypothyroidism
→ LFT for liver disease

□ BM examination: only when uncertain diagnosis or pancytopenia

72
Q

Causes of false positive macrocytosis

A

Consider factitious cause, eg. RBC clumping, osmotic swelling with hyperGly or prolonged storage, EDTA tube

73
Q

Megaloblastic anaemia

Cause

Pathogenesis

A

Megaloblastic anaemia: due to delay in maturation of nucleus relative to cytoplasm

□ Result from defective DNA synthesis → delayed M phase entry → continuous ↑cytoplasmic size without mitosis (nuclear-cytoplasmic dyssynchrony)

□ Deficiency in vitamin B12 (vast majority) or folate

74
Q

Source and absorption of Folate

A

Found in leafy vegetables (spinach, broccoli, lettuce), fruits (banana, melon) and animal protein (liver, kidney)

Seldom deficient with any normal diet in developed countries (>50μg/d)

Absorbed folate converted to methyl tetrahydrofolate (THF) by small intestines then transported inside plasma

Total body stores small → deficiency occur in weeks

75
Q

Source and absorption of Vitamin B12

A

Found in meat, fish, eggs, milk

Seldom deficient (>1μg/d) unless vegan diet

Bound to intrinsic factor (IF) produced by gastric parietal cells → IF-B12 complex absorbed in terminal ileum → transported in plasma while binding with transcobalamin II

Liver has 3-year stores of B12 and recycles B12 via enterohepatic cycling → takes years before deficiency manifest

76
Q

Physiological Function of B12 and folate

A
  1. Methyl B12 serves as co-factor in methylation of homocysteine into methionine with demethylation of methyl THF into THF
  2. THF converts to 5,10-methylene THF, serves as coenzyme for conversion of dUMP into dTMP for DNA synthesis
  3. Deoxyadenosyl B12 also serves as co-enzyme in conversion of methylmalonyl CoA into succinyl CoA
77
Q

Causes of Folate deficiency

A

Dietary insufficiency: usually only in poor, elderly, alcoholics

Malabsorption

High demand due to pregnancy, haemolytic anaemia, myeloproliferative diseases

Antifolate agents, eg. trimethoprim, OCP, pyrimethamine, phenytoin, methotrexate

78
Q

Causes of Vitamin B12 deficiency

A

Dietary insufficiency in long-term vegans

Gastric causes:
Pernicious anaemia
Status post-gastrectomy: 10-20% by 5y

Bowel causes:
SBIO with bacteria consuming B12 due to motility disorder, ↓γ-globulin, stagnant loop
Terminal ileal pathology, eg. Crohn’s disease
Fish tapeworm

79
Q

Pernicious anaemia

Define

Pathogenesis

Risk factors

Complications

Diagnosis

A

Define: Autoimmune disorder with atrophic gastric mucosa and loss of parietal cells

Pathogenesis: anti-IF or anti-parietal cell Ab (a/w chronic atrophic gastritis) attack parietal cells → ↓intrinsic factor production

Risk factors: Autoimmune diseases

Complications: Chronic atrophic gastritis, Gastric Cancer (achlorhydria)

Diagnosis: presence of auto-antibodies - Anti-Intrinsic Factor Ab and Anti-parietal cell antibody

80
Q

Clinical features of megaloblastic anaemia

A
  • Anaemia S/S
  • Jaundice
  • Oral: atrophic glossitis, oral ulcers, angular stomatitis
  • Skin: greying of hair, skin hyperpigmentation

Neuropsychiatric:

  • Subacute combined degeneration of cord: affects dorsal (DC-ML) and lateral columns (CST)
  • Peripheral neuropathy: classically ↑knee jerk (from SCD) + ↓ankle jerk (from PN)
  • depression, irritability, cognitive slowing, dementia, psychosis
81
Q

Investigations for Megaloblastic anaemia

A
  1. CBC: macrocytic anaemia (typically >115fL) with mild leukopenia/thrombocytopenia + ↓RET
  2. PBS: macro-ovalocytes + hypersegmented neutrophils
  3. Markers of haemolysis
  4. Serum B12 level: deficient <200pg/mL
  5. RBC folate: <150ng/mL
  6. Anti-IF, anti-parietal cell Ab for pernicious anemia
  7. Metabolite testing (MMA, homocysteine)
  8. Upper endoscopy for atrophic gastritis and CA stomach
82
Q

Management of Megaloblastic anaemia

A

Management: by replacement of B12 and/or folate

Urgent Folate with B12 supplement for severe anaemia/ symptomatic- Parental or oral

Oral B12 supplement: vegan diet require lifelong replacement

Oral folate supplement: indicated for folate deficiency and other conditions e.g. haemolytic anaemia with poor RBC survival

83
Q

S/S of iron deficiency anaemia

A

S/S anaemia: SOB on exertion, Pallor, Tiredness, Dizziness , Palpitation

Pica: desire for or compulsion to eat substances not fit as food, eg. dirt (geophagia), ice (pagophagia)

Restless leg syndrome (RLS)

Nail changes: brittle nails, koilonychias (spoon-shaped nails)

Epithelial/mucosal changes:
Atrophic glossitis with loss of tongue papillae ± tongue pain, dry mouth
→ Cheilosis (angular cheilitis)
Oesophageal webs (rare) → termed Plummer-Vinson syndrome when a/w dysphagia